Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:49 UTC |
---|
Update Date | 2022-03-07 02:51:41 UTC |
---|
HMDB ID | HMDB0014618 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Chlordiazepoxide |
---|
Description | Chlordiazepoxide is only found in individuals that have used or taken this drug. It is an anxiolytic benzodiazepine derivative with anticonvulsant, sedative, and amnesic properties. It has also been used in the symptomatic treatment of alcohol withdrawal. [PubChem]Chlordiazepoxide binds to stereospecific benzodiazepine (BZD) binding sites on GABA (A) receptor complexes at several sites within the central nervous system, including the limbic system and reticular formation. This results in an increased binding of the inhibitory neurotransmitter GABA to the GABA(A) receptor.BZDs, therefore, enhance GABA-mediated chloride influx through GABA receptor channels, causing membrane hyperpolarization. The net neuro-inhibitory effects result in the observed sedative, hypnotic, anxiolytic, and muscle relaxant properties. |
---|
Structure | CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=N(=O)C1 InChI=1S/C16H14ClN3O/c1-18-15-10-20(21)16(11-5-3-2-4-6-11)13-9-12(17)7-8-14(13)19-15/h2-9H,10H2,1H3,(H,18,19) |
---|
Synonyms | Value | Source |
---|
7-Chloro-2-methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide | ChEBI | CDP | ChEBI | Chlordiazepoxide base | ChEBI | Chlordiazepoxidum | ChEBI | Clopoxide | ChEBI | Helogaphen | ChEBI | Libritabs | ChEBI | Methaminodiazepoxide | ChEBI | Multum | ChEBI | Risolid | ChEBI | Silibrin | ChEBI | Tropium | ChEBI |
|
---|
Chemical Formula | C16H14ClN3O |
---|
Average Molecular Weight | 299.755 |
---|
Monoisotopic Molecular Weight | 299.082539792 |
---|
IUPAC Name | 7-chloro-2-(methylamino)-5-phenyl-3H-1,4λ⁵-benzodiazepin-4-one |
---|
Traditional Name | multum |
---|
CAS Registry Number | 58-25-3 |
---|
SMILES | CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=N(=O)C1 |
---|
InChI Identifier | InChI=1S/C16H14ClN3O/c1-18-15-10-20(21)16(11-5-3-2-4-6-11)13-9-12(17)7-8-14(13)19-15/h2-9H,10H2,1H3,(H,18,19) |
---|
InChI Key | ANTSCNMPPGJYLG-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 1,4-benzodiazepines. These are organic compounds containing a benzene ring fused to a 1,4-azepine. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Benzodiazepines |
---|
Sub Class | 1,4-benzodiazepines |
---|
Direct Parent | 1,4-benzodiazepines |
---|
Alternative Parents | |
---|
Substituents | - 1,4-benzodiazepine
- Aryl chloride
- Aryl halide
- Monocyclic benzene moiety
- Benzenoid
- Imidolactam
- Nitrone
- Azacycle
- Carboxylic acid amidine
- Allyl-type 1,3-dipolar organic compound
- Propargyl-type 1,3-dipolar organic compound
- Organic 1,3-dipolar compound
- Amidine
- Organonitrogen compound
- Organochloride
- Organohalogen compound
- Organic nitrogen compound
- Organic zwitterion
- Organic oxide
- Hydrocarbon derivative
- Organic oxygen compound
- Organopnictogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 236.2 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.02 g/L | Not Available | LogP | 1.7 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross SectionsAdduct Type | Data Source | CCS Value (Å2) | Reference |
---|
[M+H]+ | CBM | 170.4 | 30932474 |
|
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Chlordiazepoxide,1TMS,isomer #1 | CN(C1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1)[Si](C)(C)C | 2639.0 | Semi standard non polar | 33892256 | Chlordiazepoxide,1TMS,isomer #1 | CN(C1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1)[Si](C)(C)C | 2642.7 | Standard non polar | 33892256 | Chlordiazepoxide,1TMS,isomer #1 | CN(C1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1)[Si](C)(C)C | 3604.9 | Standard polar | 33892256 | Chlordiazepoxide,1TBDMS,isomer #1 | CN(C1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1)[Si](C)(C)C(C)(C)C | 2822.4 | Semi standard non polar | 33892256 | Chlordiazepoxide,1TBDMS,isomer #1 | CN(C1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1)[Si](C)(C)C(C)(C)C | 2862.5 | Standard non polar | 33892256 | Chlordiazepoxide,1TBDMS,isomer #1 | CN(C1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1)[Si](C)(C)C(C)(C)C | 3669.0 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Chlordiazepoxide CI-B (Non-derivatized) | splash10-0udi-0079000000-a3045f81d776a5127fe9 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Chlordiazepoxide EI-B (Non-derivatized) | splash10-001i-5590000000-a20477457b7e9f8a22ea | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Chlordiazepoxide CI-B (Non-derivatized) | splash10-0udi-0079000000-a3045f81d776a5127fe9 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Chlordiazepoxide EI-B (Non-derivatized) | splash10-001i-5590000000-a20477457b7e9f8a22ea | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Chlordiazepoxide GC-MS (Non-derivatized) - 70eV, Positive | splash10-0ce9-3190000000-fd85fc0a63c0f6fa743a | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Chlordiazepoxide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Chlordiazepoxide LC-ESI-QTOF , positive-QTOF | splash10-001i-0090000000-a293b353926a16c4d11a | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Chlordiazepoxide , positive-QTOF | splash10-004i-2590000000-965415c5fb9e79098c6d | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Chlordiazepoxide -1V, Positive-QTOF | splash10-001i-0090000000-c7b6568f60df163a9045 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlordiazepoxide 10V, Positive-QTOF | splash10-0udi-0009000000-145539550957c8a47ff2 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlordiazepoxide 20V, Positive-QTOF | splash10-0udi-2039000000-5d3fa4444adf37869d3a | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlordiazepoxide 40V, Positive-QTOF | splash10-0a4i-9000000000-23b22bc4629e93465c34 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlordiazepoxide 10V, Negative-QTOF | splash10-0002-0090000000-cae96ea0a93acd325b0a | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlordiazepoxide 20V, Negative-QTOF | splash10-0002-1090000000-e599edf7db7a647524e4 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlordiazepoxide 40V, Negative-QTOF | splash10-0a6r-9030000000-ed7b2614fcfebabd55db | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlordiazepoxide 10V, Positive-QTOF | splash10-0udi-0009000000-20c277fa4f0e38cb4802 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlordiazepoxide 20V, Positive-QTOF | splash10-0udi-0029000000-72801e1fa9da3f451f42 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlordiazepoxide 40V, Positive-QTOF | splash10-02tc-1290000000-0b39e76350bab6708551 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlordiazepoxide 10V, Negative-QTOF | splash10-0002-0090000000-d48fa0574ae5210c8c30 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlordiazepoxide 20V, Negative-QTOF | splash10-00kb-2090000000-459de3a61617176e7e3b | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlordiazepoxide 40V, Negative-QTOF | splash10-0gc0-9010000000-5ae42ebf2246e4f7b539 | 2021-09-22 | Wishart Lab | View Spectrum |
|
---|
General References | - Skerritt JH, Johnston GA: Enhancement of GABA binding by benzodiazepines and related anxiolytics. Eur J Pharmacol. 1983 May 6;89(3-4):193-8. [PubMed:6135616 ]
- Vozeh S: [Pharmacokinetic of benzodiazepines in old age]. Schweiz Med Wochenschr. 1981 Nov 21;111(47):1789-93. [PubMed:6118950 ]
- Earley JV, Fryer RI, Ning RY: Quinazolines and 1,4-benzodiazepines. LXXXIX: Haptens useful in benzodiazepine immunoassay development. J Pharm Sci. 1979 Jul;68(7):845-50. [PubMed:458601 ]
- Olive G, Dreux C: [Pharmacologic bases of use of benzodiazepines in pereinatal medicine]. Arch Fr Pediatr. 1977 Jan;34(1):74-89. [PubMed:851373 ]
- Oishi R, Nishibori M, Itoh Y, Saeki K: Diazepam-induced decrease in histamine turnover in mouse brain. Eur J Pharmacol. 1986 May 27;124(3):337-42. [PubMed:3089825 ]
|
---|